학술논문
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Document Type
Article
Author
Source
In: Blood Advances . (Blood Advances, 12 September 2023, 7(17):4950-4961)
Subject
Language
English
ISSN
24739537
24739529
24739529